These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 32676989)
1. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1 Lee JD; McDonald TS; Fung JNT; Woodruff TM Mol Neurobiol; 2020 Oct; 57(10):4143-4155. PubMed ID: 32676989 [TBL] [Abstract][Full Text] [Related]
2. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1 MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712 [TBL] [Abstract][Full Text] [Related]
3. Effects of RAGE inhibition on the progression of the disease in hSOD1 Liu L; Killoy KM; Vargas MR; Yamamoto Y; Pehar M Pharmacol Res Perspect; 2020 Aug; 8(4):e00636. PubMed ID: 32776498 [TBL] [Abstract][Full Text] [Related]
4. The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice. Nowicka N; Szymańska K; Juranek J; Zglejc-Waszak K; Korytko A; Załęcki M; Chmielewska-Krzesińska M; Wąsowicz K; Wojtkiewicz J Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216298 [TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model. Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1 Lee JD; Liu N; Levin SC; Ottosson L; Andersson U; Harris HE; Woodruff TM J Neuroinflammation; 2019 Feb; 16(1):45. PubMed ID: 30782181 [TBL] [Abstract][Full Text] [Related]
7. Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice. Nowicka N; Zglejc-Waszak K; Juranek J; Korytko A; Wąsowicz K; Chmielewska-Krzesińska M; Wojtkiewicz J PLoS One; 2024; 19(3):e0299567. PubMed ID: 38457412 [TBL] [Abstract][Full Text] [Related]
8. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. Lee JY; Lee JD; Phipps S; Noakes PG; Woodruff TM J Neuroinflammation; 2015 May; 12():90. PubMed ID: 25962427 [TBL] [Abstract][Full Text] [Related]
9. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
10. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1 Wang HA; Lee JD; Lee KM; Woodruff TM; Noakes PG Skelet Muscle; 2017 Jun; 7(1):10. PubMed ID: 28571586 [TBL] [Abstract][Full Text] [Related]
11. Desloratadine alleviates ALS-like pathology in hSOD1 Lu J; He AX; Jin ZY; Zhang M; Li ZX; Zhou F; Ma L; Jin HM; Wang JY; Shen X Acta Pharmacol Sin; 2024 May; 45(5):926-944. PubMed ID: 38286832 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1 Shang HY; Zhang JJ; Fu ZF; Liu YF; Li S; Chen S; Le WD CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169 [TBL] [Abstract][Full Text] [Related]
13. Complement components are upregulated and correlate with disease progression in the TDP-43 Lee JD; Levin SC; Willis EF; Li R; Woodruff TM; Noakes PG J Neuroinflammation; 2018 Jun; 15(1):171. PubMed ID: 29859100 [TBL] [Abstract][Full Text] [Related]
14. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1 Winter AN; Ross EK; Wilkins HM; Stankiewicz TR; Wallace T; Miller K; Linseman DA Nutr Neurosci; 2018 Jul; 21(6):414-426. PubMed ID: 28276271 [TBL] [Abstract][Full Text] [Related]
15. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1 Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622 [TBL] [Abstract][Full Text] [Related]
16. IRAK-M Plays A Role in the Pathology of Amyotrophic Lateral Sclerosis Through Suppressing the Activation of Microglia. Zhong X; Li C; Li Y; Huang Y; Liu J; Jiang A; Chen J; Peng Y Mol Neurobiol; 2024 Oct; 61(10):7603-7610. PubMed ID: 38421467 [TBL] [Abstract][Full Text] [Related]